Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2013 Jul;22(7):1227–1238. doi: 10.1158/1055-9965.EPI-12-1432

Table 4.

Association of race with treatment delays of >30 days in the study population

Odds Ratio (95% CI)
Race, Age range Crude Model Model 1 Model 2 Fully Adjusted Model
White, 20–39 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
African American, 20–39 1.75 (0.66–4.66) 1.52 (0.55–4.15) 1.91 (0.68–5.37) 3.34(1.07–10.38)**
White, 40–49 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
African American, 40–49 2.61 (1.50–4.56)* 2.45 (1.37–4.39)* 2.56 (1.42–4.64)* 3.40(1.76–6.54)*
White, 50–64 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
African American, 50–64 0.79 (0.46–1.36) 0.84 (0.47–1.52) 0.84 (0.46–1.52) 0.95 (0.51–1.77)
White, 65–74 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
African American, 65–74 1.27 (0.54–2.94) 1.38 (0.54–3.53) 1.34 (0.51–3.51) 1.45 (0.54–3.91)

White, 20–39 0.60 (0.28–1.29) 0.64 (0.29–1.42) 0.57 (0.25–1.30) 0.32(0.13–0.80)**
White, 40–49 0.47 (0.26–0.82)* 0.52 (0.29–0.93)** 0.49 (0.27–0.89)** 0.38(0.20–0.73)*
White, 50–64 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
White, 65–74 0.64 (0.33–1.24) 0.81 (0.37–1.78) 0.77 (0.34–1.75) 0.87(0.38–2.02)

African American, 20–39 1.32 (0.59–2.97) 1.15 (0.50–2.67) 1.30 (0.55–3.08) 1.12(0.44–2.86)
African American, 40–49 1.54 (0.90–2.63) 1.49 (0.85–2.62) 1.48 (0.84–2.63) 1.37(0.75–2.48)
African American, 50–64 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
African American, 65–74 1.03 (0.48–2.20) 1.32 (0.54–3.20) 1.23 (0.50–3.03) 1.33(0.52–3.40)

CI: confidence interval; Crude Model: adjusted for age, race x age; Model 1: adjusted for age, race x age, income, insurance; Model 2: adjusted for Model 1 variables, education, lost job; Fully Adjusted Model: adjusted for Model 2 variables, marital status, disease stage, symptoms, first treatment/reconstruction

*

P < 0.01

**

P < 0.05